Camurus invite you to join a panel of Australian experts including Professor Nick Lintzeris, Professor Adrian Dunlop, Dr Mary Harrod and Dr Craig Rogers to explore how long-acting injectable buprenorphine (LAIB) has impacted the treatment of opioid dependence in Australia. They will unpick the challenges, access, and explore ways to optimise care for people living with opioid dependence. The 4 key areas for the discussion include, the role of digital health, the role of pharmacy, integration of LAIB into services and the perspective of the service users.
